GCPEF yields 1428.57% · JNJ yields 2.13%● Live data
📍 GCPEF pulled ahead of the other in Year 1
Combined, GCPEF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GCPEF + JNJ for your $10,000?
GCL Technology Holdings Limited manufactures and sells polysilicon and wafers products in the People's Republic of China and internationally. It operates through three segments: Solar Material Business, Solar Farm Business, and New Energy Business. The Solar Material Business segment primarily manufactures and sells polysilicon and wafer products to companies operating in the solar industry. The Solar Farm Business segment operates and manages 18 MW solar farms located in the United States and 150 MW solar farms situated in South Africa; and 5 solar farms in the People's Republic of China. The New Energy Business segment develops, constructs, operates, and manages solar farms. The company was formerly known as GCL-Poly Energy Holdings Limited and changed its name to GCL Technology Holdings Limited in April 2022. GCL Technology Holdings Limited was incorporated in 2006 and is based in Kowloon, Hong Kong.
Full GCPEF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.